Wang, Xicheng

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

Cheng, Y., Han, L., Wu, L., Chen, J., Sun, H., Wen, G., Ji, Y., Dvorkin, M., Shi, J., Pan, Z., et al. (2022) · JAMA

Lung Cancer Research StudiesCancer Immunotherapy and Biomarkers

Cited by 492

The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer

Peng, Z., Cheng, S., Kou, Y., Wang, Z., Jin, R., Hu, H., Zhang, X., Gong, J.-F., Li, J., Lu, M., et al. (2020) · Cancer Immunology Research

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 361

Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma

Cai, Y., Fu, Y., Liu, C., Wang, X., You, P., Li, X., Song, Y., Mu, X., Fang, T., Yang, Y., et al. (2022) · Cell Death & Disease

Hepatocellular Carcinoma Treatment and PrognosisMicroRNA in disease regulation

Cited by 44

Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non–Small Cell Lung Cancer: The Phase II TRUST-I Study

Li, W., Xiong, A., Yang, N., Fan, H., Yu, Q., Zhao, Y., Wang, Y., Meng, X., Wu, J., Wang, Z., et al. (2024) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 40

Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors

Xu, T., Wang, X., Wang, Z., Deng, T., Qi, C., Liu, D., Li, Y., Ji, C., Li, J., & Shen, L. (2022) · Therapeutic Advances in Medical Oncology

Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations

Cited by 38

Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer

Zhuo, N., Liu, C., Zhang, Q., Li, J., Zhang, X., Gong, J., Lu, M., Peng, Z., Zhou, J., Wang, X., et al. (2022) · JAMA Network Open

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Cited by 30

Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer

Xu, T., Li, J., Wang, Z., Zhang, X., Zhou, J., Lu, Z., Shen, L., & Wang, X. (2023) · Cancer Medicine

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 20

A passage-dependent network for estimating the in vitro senescence of mesenchymal stromal/stem cells using microarray, bulk and single cell RNA sequencing

Yang, Y., Zhang, W., Wang, X., Yang, J., Cui, Y., Song, H., Li, W., Li, W., Wu, L., Du, Y., et al. (2023) · Frontiers in Cell and Developmental Biology

Mesenchymal stem cell researchTelomeres, Telomerase, and Senescence

Cited by 16